Tag: Big pharma

Healthcare

Australia’s Capability in Clinical Trials

Earlier this year, Austrade released the new Clinical Trials industry capability report which highlights why Australia is a leading destination for clinical research of new therapeutic products and medical devices. The report showcases Australia’s strengths in the sector—world-class medical research infrastructure, an efficient regulatory system, a strong and stable business environment, and generous tax incentives—that make it…

24 Jul 2018, by Francesca Brewer

Healthcare

Status Quo or No? 2017 Completed Clinical Trials

A completed clinical trial landscape provides a more granular view of how companies are progressing their pipelines and the disease strategies they are pursuing, compared to static pipeline snapshots. Company pipeline depictions lack the underlying intelligence that illustrates just how a candidate progressed, or perhaps disappeared altogether from a disease pipeline. As part of our…

13 Jul 2018, by Francesca Brewer

Business

Technology

What’s so super about super incubators?

 < Petra Andren, CEO, Cicada Innovations We’ve been talking about innovation for a while now. Its connection to jobs and growth. Its role in preventing Australia from being left behind in a rapidly changing global landscape. And as a part of this national discussion, Innovation and Science Australia recently released its NISA Strategic Plan 2030.…

12 Jul 2018, by Amy Sarcevic

Healthcare

Close-Up: David Gallagher

David Gallagher was appointed as Chairman and Managing Director of Pfizer Australia in early 2013. He joined Pfizer Healthcare Ireland 12 years ago and led the business as Managing Director from May 2007 before taking on the role in Australia. David will be speaking at the 11th Annual Future of the PBS Summit on the 5th and…

25 Mar 2014, by test test